As part of our ongoing aim to bring you reports of new developments, we have added a review of a recent study: Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER.
These trials were both placebo-controlled, randomised trials and independent commentary for the review has been provided by Professor Andrew Sindone, Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital.
Please login below to download this issue (PDF)